Stockscreener 앱 받기
7.58
0.66%
-0.05
시간 외 거래:
7.61
0.03
+0.40%
전일 마감가:
$7.63
열려 있는:
$7.67
하루 거래량:
830.21K
Relative Volume:
0.67
시가총액:
$404.40M
수익:
$1.02B
순이익/손실:
$-757.20M
주가수익비율:
-0.5136
EPS:
-14.76
순현금흐름:
$-257.90M
1주 성능:
-8.67%
1개월 성능:
+24.26%
6개월 성능:
+30.69%
1년 성능:
-0.66%
1일 변동 폭
$7.51
$7.8201
1주일 범위
$7.51
$8.62
52주 변동 폭
$4.02
$12.73
Emergent Biosolutions Inc Stock (EBS) Company Profile
명칭
Emergent Biosolutions Inc
전화
240-631-3200
주소
300 PROFESSIONAL DR, GAITHERSBURG, MD
EBS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
7.58 | 407.07M | 1.02B | -757.20M | -257.90M | -14.76 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2024-03-07 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-11-20 | 재개 | JP Morgan | Underweight |
| 2023-08-29 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-04-10 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-03-17 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-11-10 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-04-29 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2021-11-08 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-05-05 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 개시 | The Benchmark Company | Buy |
| 2021-02-24 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | 재개 | JP Morgan | Neutral |
| 2020-07-31 | 재확인 | Chardan Capital Markets | Buy |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-09-04 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-08-03 | 재확인 | Chardan Capital Markets | Buy |
| 2018-06-13 | 개시 | Argus | Buy |
| 2018-04-25 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2018-01-16 | 재확인 | Chardan Capital Markets | Buy |
| 2016-06-28 | 재확인 | Singular Research | Buy |
| 2016-04-15 | 개시 | Chardan Capital Markets | Buy |
| 2016-03-28 | 개시 | Singular Research | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2014-05-15 | 개시 | Summer Street Research | Buy |
| 2011-05-31 | 재확인 | WBB Securities | Strong Buy |
| 2011-01-10 | 재확인 | Wedbush | Outperform |
| 2010-11-05 | 재확인 | Wedbush | Outperform |
| 2010-08-18 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | 재확인 | Caris & Company | Buy |
모두보기
Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스
Is Emergent BioSolutions Inc. trending in predictive chart modelsTrade Analysis Report & Daily Volume Surge Signals - Newser
How to build a custom watchlist for Emergent BioSolutions Inc.Watch List & Daily Chart Pattern Signals - Newser
Will earnings trigger a reversal in Emergent BioSolutions Inc.2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
What’s the beta of Emergent BioSolutions Inc. stockWeekly Risk Summary & Advanced Technical Signal Analysis - خودرو بانک
Will Emergent BioSolutions Inc. face regulatory challenges2025 Market Overview & Smart Swing Trading Alerts - خودرو بانک
Is Emergent BioSolutions Inc. showing insider buyingMarket Performance Report & Verified Technical Signals - خودرو بانک
Will Emergent BioSolutions Inc. outperform the marketM&A Rumor & Daily Stock Trend Reports - Newser
Smart tools for monitoring Emergent BioSolutions Inc.’s price action2025 Fundamental Recap & AI Based Buy and Sell Signals - Newser
Emergent BioSolutions Inc. stock retracement – recovery analysisTrade Risk Assessment & Low Volatility Stock Suggestions - Newser
Real time scanner hits for Emergent BioSolutions Inc. explained2025 Technical Patterns & Risk Controlled Swing Alerts - Newser
Backtesting results for Emergent BioSolutions Inc. trading strategies2025 Analyst Calls & Momentum Based Trading Signals - Newser
Is Emergent BioSolutions Inc. forming a bottoming basePortfolio Return Summary & Capital Protection Trade Alerts - Newser
Emergent BioSolutions at Wells Fargo Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Building trade automation scripts for Emergent BioSolutions Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - Newser
Can swing trading help recover from Emergent BioSolutions Inc. lossesMarket Performance Summary & Fast Exit and Entry Trade Guides - Newser
Emergent BioSolutions at Wells Fargo Conference: Strategic Growth Insights - Investing.com
Sector ETF performance correlation with Emergent BioSolutions Inc.Earnings Growth Report & High Accuracy Swing Trade Signals - Newser
Heatmap analysis for Emergent BioSolutions Inc. and competitorsLong Setup & Community Supported Trade Ideas - Newser
What data driven models say about Emergent BioSolutions Inc.’s futureJuly 2025 Reactions & Verified Swing Trading Watchlist - Newser
Real time breakdown of Emergent BioSolutions Inc. stock performanceWeekly Trend Recap & Capital Efficiency Focused Ideas - Newser
Is Emergent BioSolutions Inc. meeting your algorithmic filter criteriaMarket Performance Report & Advanced Technical Signal Analysis - Newser
Can Emergent BioSolutions Inc. continue delivering strong returnsBond Market & AI Optimized Trade Strategies - خودرو بانک
Order flow analysis tools used on Emergent BioSolutions Inc.July 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Tools to monitor Emergent BioSolutions Inc. recovery probabilityPortfolio Gains Summary & Growth Focused Entry Point Reports - Newser
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer for Anthrax Treatment - MSN
Ranking Emergent BioSolutions Inc. among high performing stocks via toolsJuly 2025 Retail & Capital Efficiency Focused Ideas - Newser
Is Emergent BioSolutions Inc. stock bottoming outJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser
Does Emergent BioSolutions Inc. stock benefit from AI growth2025 Year in Review & Daily Market Momentum Tracking - خودرو بانک
Mineralys’ strategic stock sale; Gilead, Shoreline partnership ends - Endpoints News
What high frequency data says about Emergent BioSolutions Inc.July 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
Can Emergent BioSolutions Inc. hit a new high this monthBear Alert & Expert Curated Trade Setups - Newser
Tools to assess Emergent BioSolutions Inc.’s risk profile2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Emergent: HC Wainwright & Co. reiterates the 'Buy' Rating, The Target Price is $15 - AInvest
Is Emergent BioSolutions Inc. stock reversal real or fake2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Risk vs reward if holding onto Emergent BioSolutions Inc.July 2025 Reactions & Consistent Profit Trade Alerts - Newser
Applying sector rotation models to Emergent BioSolutions Inc.Global Markets & Daily Technical Forecast Reports - Newser
Can a trend reversal in Emergent BioSolutions Inc. lead to recoveryBear Alert & Momentum Based Trading Ideas - Newser
Can trapped investors hope for a rebound in Emergent BioSolutions Inc.2025 Valuation Update & Long-Term Growth Stock Strategies - Newser
Custom watchlist performance reports with Emergent BioSolutions Inc.July 2025 Pullbacks & Safe Capital Growth Stock Tips - Newser
Will Emergent BioSolutions Inc. benefit from green energy policies2025 Price Targets & Community Consensus Trade Alerts - خودرو بانک
Is now a turning point for Emergent BioSolutions Inc.Weekly Market Report & Safe Capital Growth Tips - Newser
Using data models to predict Emergent BioSolutions Inc. stock movementMarket Activity Recap & Real-Time Market Trend Scan - Newser
Emergent Biosolutions Inc (EBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.53%
자본화:
|
볼륨(24시간):